Hadassah

Hadassah Clinical Trial Reveals Safety and Efficacy of Stem Cell Technology in Treating ALS

Wednesday, Feb 15 2012

"This may represent the biggest hope in the field of degenerative diseases like ALS," Prof. Dimitrios Karussis, head of the Hadassah University Medical Center's Multiple Sclerosis Center, said about the clinical trial just completed at Hadassah where stem cells were used to treat Amyotrophic Lateral Sclerosis (ALS).

Even though this was a trial to determine the safety of the technology, early clinical follow up of the patients demonstrated an improvement in breathing and swallowing ability as well as in muscular power. "I am very excited about the safety results, as well as the indications of efficacy," Prof. Karussis said. The initial patients who were treated with BrainStorm Cell Therapeutics' NurOwn™ stem cell technology experienced no significant side effects in this Phase I/II clinical trial. As a result, Hadassah's ethics and safety committee has now granted BrainStorm approval to proceed with treating additional patients.

NurOwn™ technology processes adult human stem cells that are present in bone marrow and are capable of self-renewal and differentiation into many other cell types. A progressive neurodegenerative disease, ALS, often referred to as Lou Gehrig's disease, affects nerve cells in the brain and the spinal cord. With this technology, the bone marrow cells are induced to differentiate into cells capable of releasing neurotrophic factors which can help ALS patients. According to the ALS Association, approximately 5,600 people in the United States are diagnosed with ALS each year and it is estimated that as many as 30,000 Americans may have the disease at any given time.

The study, led by Prof. Karussis, is being conducted in conjunction with a scientific team from BrainStorm.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, May 23 2017

First Ladies Melania Trump and Sara Netanyahu Visit Hadassah Hospital

Please share our pride in Hadassah Hospital, singled out by the Israeli government to showcase the nation’s top-quality medicine, top doctors, and innovative medical research. First Lady Melania Trump and First Lady Sara Netanyahu visited Hadassah Hospital Ein Kerem on May 22...

READ MORE ›
alt_text

Wednesday, May 10 2017

Hadassah’s Melanoma Maven Featured in Hadassah Magazine

Metastatic melanoma is typically fatal, but Hadassah Hospital’s Prof. Michal Lotem, a world-renowned, cutting-edge physician/scientist, is trailblazing new treatments that are being watched around the globe.

READ MORE ›
alt_text

Monday, May 1 2017

Hadassah Surgeon to Light Torch at Jerusalem Independence Day Ceremony

Meet Prof. Ahmed Eid of Hadassah Hospital, who will light the torch at Jerusalem's Independence Day Ceremony, in honor of the city’s doctors who tirelessly work to save lives and improve the quality of life of men, women and children.

READ MORE ›

Friday, Apr 28 2017

Surgeons Perform World’s First-Ever Dual Robotic Surgery
 at Jerusalem’s Hadassah Hospital

The world’s first-of-its-kind dual robotic surgery was performed on April 23 at Hadassah Hospital Ein Kerem in Jerusalem, announced National President Ellen Hershkin of Hadassah, the Women’s Zionist Organization of America, Inc. (HWZOA).

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More